Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eisai Deal Puts Epizyme In Position To Advance Lead Program

This article was originally published in The Pink Sheet Daily

Executive Summary

Deal with Eisai on epigenetic enzymes is collaborative, whereas in recent tie up with GSK, Epizyme gave up control of development and commercialization of select histone methyltransferases.
Advertisement

Related Content

Eisai Cancer Subsidiary H3 Pushes Toward The Clinic
Epizyme Builds A Cancer Company At Mach Speed
Epigenetic Modifiers Take Center Stage, Big Pharma Takes Notice
Genentech, Constellation Enter Largest Epigenetics Tie-Up Yet
AACR’s “Most Likely To Succeed” Anticancer Technologies
AACR’s “Most Likely To Succeed” Anticancer Technologies
Eisai Revises Global Sales Strategy; Slashes U.S. Staff, Finds Ways To Retain Chinese Workers
GSK Teams Up With EpiZyme To Develop Epigenetic Drugs
GSK Teams Up With EpiZyme To Develop Epigenetic Drugs
Epizyme Emerges From Stealth Mode

Topics

Advertisement
UsernamePublicRestriction

Register

PS071932

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel